A novel strain of human coronaviruses, named by the International Committee on Taxonomy of Viruses (ICTV)1 as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has emerged and caused an infectious disease. This disease has recently been referred to by the World Health Organisation (WHO) as the “coronavirus disease 2019” (COVID-19). Since the first report of this disease in December 2019 in Wuhan, China,2, 3 COVID-19 has aggressively spread across the globe. WHO declared it a pandemic on March 11.
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement
Maria-Teresa Ventura;
2020-01-01
Abstract
A novel strain of human coronaviruses, named by the International Committee on Taxonomy of Viruses (ICTV)1 as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has emerged and caused an infectious disease. This disease has recently been referred to by the World Health Organisation (WHO) as the “coronavirus disease 2019” (COVID-19). Since the first report of this disease in December 2019 in Wuhan, China,2, 3 COVID-19 has aggressively spread across the globe. WHO declared it a pandemic on March 11.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Intranasal.pdf
accesso aperto
Tipologia:
Documento in Versione Editoriale
Licenza:
Creative commons
Dimensione
515.09 kB
Formato
Adobe PDF
|
515.09 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
